FLSM
CERE
Frazier Life Sciences Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-393,000
| Closed | -$16.1M | – | 57 |
|
|
2024
Q2 | $16.1M | Hold |
393,000
| – | – | 0.75% | 30 |
|
|
2024
Q1 | $16.6M | Hold |
393,000
| – | – | 0.7% | 33 |
|
|
2023
Q4 | $16.7M | Hold |
393,000
| – | – | 0.89% | 30 |
|
|
2023
Q3 | $8.58M | Hold |
393,000
| – | – | 0.57% | 34 |
|
|
2023
Q2 | $12.5M | Hold |
393,000
| – | – | 0.75% | 30 |
|
|
2023
Q1 | $9.59M | Hold |
393,000
| – | – | 0.69% | 30 |
|
|
2022
Q4 | $12.4M | Hold |
393,000
| – | – | 0.77% | 26 |
|
|
2022
Q3 | $11.1M | Buy |
393,000
+190,740
| +94% | +$5.39M | 0.86% | 28 |
|
|
2022
Q2 | $5.35M | Buy |
202,260
+146,425
| +262% | +$3.87M | 0.5% | 32 |
|
|
2022
Q1 | $1.96M | Buy |
+55,835
| New | +$1.96M | 0.17% | 40 |
|